Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 3:24 pm Purchase | 2025-03-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Armistice Capital, LLC | 24,844,725 9.200% | 24,003,030 (+2851.75%) | Filing History |
| 2025-03-04 10:32 am Purchase | 2025-02-26 | 13D | Cyclacel Pharmaceuticals, Inc. CYCC | Doris Wong Sing Ee | 12,164,301 70.000% | 12,164,301 (New Position) | Filing History |
| 2025-02-28 4:46 pm Purchase | 2025-02-06 | 13D | Cyclacel Pharmaceuticals, Inc. CYCC | Lazar David E. | 2,438,824 15.840% | 2,438,824 (New Position) | Filing History |
| 2025-02-14 5:40 pm Purchase | 2024-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Armistice Capital, LLC | 52,606 9.990% | 38,690 (+278.03%) | Filing History |
| 2024-11-14 7:21 pm Sale | 2024-09-30 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Lind Global Fund II LP | 0 0.000% | -6,391 (Position Closed) | Filing History |
| 2024-11-14 3:27 pm Purchase | 2024-09-30 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Armistice Capital, LLC | 13,916 9.990% | 13,916 (New Position) | Filing History |
| 2024-02-14 4:31 pm Sale | 2023-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Schonfeld Strategic Advisors LLC | 119 0.180% | -3,091 (-96.30%) | Filing History |
| 2024-02-14 10:09 am Sale | 2023-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Dellora Investments Master Fund LP | 0 0.000% | -2,703 (Position Closed) | Filing History |
| 2024-02-13 3:47 pm Unchanged | 2023-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Altium Capital Management LLC | 12,131 4.990% | 0 (Unchanged) | Filing History |
| 2024-02-07 5:03 pm Sale | 2023-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | ACORN BIOVENTURES, L.P. | 0 0.000% | -11,730 (Position Closed) | Filing History |
| 2024-01-10 1:35 pm Purchase | 2023-12-21 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Altium Capital Management LLC | 12,131 8.000% | 12,131 (New Position) | Filing History |
| 2024-01-04 4:30 pm Purchase | 2023-12-26 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Lind Global Fund II LP | 6,391 9.900% | 6,391 (New Position) | Filing History |
| 2023-02-14 4:31 pm Purchase | 2022-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Schonfeld Strategic Advisors LLC | 3,210 6.140% | 3,210 (New Position) | Filing History |
| 2023-02-13 4:16 pm Unchanged | 2022-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Dellora Investments Master Fund LP | 2,703 5.200% | 0 (Unchanged) | Filing History |
| 2023-02-06 11:27 am Sale | 2022-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | SPHERA FUNDS MANAGEMENT LTD. | 1,042 1.990% | -1,076 (-50.82%) | Filing History |
| 2023-01-26 1:36 pm Purchase | 2022-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | ACORN BIOVENTURES, L.P. | 11,730 9.990% | 1,961 (+20.07%) | Filing History |
| 2022-08-22 1:17 pm Purchase | 2022-08-11 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Dellora Investments Master Fund LP | 2,703 5.200% | 2,703 (New Position) | Filing History |
| 2022-02-14 4:34 pm Sale | 2021-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Ikarian Capital, LLC | 414 1.000% | -1,252 (-75.14%) | Filing History |
| 2022-02-14 06:15 am Purchase | 2021-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | SPHERA FUNDS MANAGEMENT LTD. | 2,118 5.100% | 6 (+0.30%) | Filing History |
| 2022-02-04 4:03 pm Unchanged | 2021-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Hudson Bay Capital Management LP | 1,719 3.970% | 0 (Unchanged) | Filing History |